Clinical Study

Avoiding the Learning Curve for Transcatheter Aortic Valve Replacement

Table 1

Baseline characteristics.

ParameterEstablished program overall New program overall New program
First half Second half

Clinical characteristics
Age (years)81.4 ± 9.178.9 ± 8.70.0879 (±8)78 (±9)0.47
Male gender53% (115)100% (50)<0.01100%100%NA
STS Score8.0 ± 4.76.8 ± 6.00.156.2 ± 57.4 ± 70.25
Height (cm)167 ± 11172 ± 7.4<0.01171 ± 7.5173 ± 7.40.57
Weight (kg)81 ± 2492 ± 25<0.0193 ± 31.591 ± 170.84
Ejection fraction52.9 ± 12.150.3 ± 11.20.1551.7 ± 11.248.8 ± 11.20.37
Heart failure33% (73)12% (6)<0.010% (0)24% (6)0.02
Myocardial infarction28% (61)15% (7)<0.018% (2)21% (5)0.42
PCI36% (79)35% (17)0.8620% (5)50% (12)0.04
Atrial fibrillation44% (97)42% (21)0.7740% (10)44% (11)0.78
Stroke15% (32)16% (8)0.764% (1)29% (7)0.02
Porcelain aorta6% (14)4% (2)0.748% (2)0% (0)0.49
Pacemaker13% (29)10% (5)0.648% (2)12% (3)1.00
Smoker7% (16)6% (3)1.004% (1)8% (2)1.00
Hypertension89% (195)52% (26)<0.0152% (13)52% (13)1.00
Dialysis5% (10)12% (6)0.058% (2)16% (4)0.67
PAD33% (72)24% (12)0.2524% (6)24% (6)0.94
Diabetes mellitus33% (73)32% (16)0.3136% (9)28% (7)0.83
Home oxygen13% (28)22% (11)0.1024% (6)20% (5)1.00
Anticoagulant19% (33)10% (5)0.158% (2)12% (3)1.00
Aortic valve measurements
Area0.82 ± 0.520.76 ± 0.230.430.72 ± 0.220.80 ± 0.230.27
Peak velocity4.2 ± 0.693.9 ± 0.680.014.1 ± 0.73.7 ± 0.60.03
Mean gradient43.9 ± 1438.2 ± 14.20.0142.2 ± 16.534.4 ± 10.60.05
Procedural characteristics
Transfemoral access61% (138)70% (35)0.2564%76%0.36
Alternative access39% (87)30% (15)0.2536%24%0.36
Balloon-expandable79% (171)80% (40)0.6184%76%0.73
Self-expandable21% (52)20% (10)0.6116%24%0.73
Valve size (mm)26 ± 2.527.7 ± 2.2<0.0127.5 (±2)27.9 (±2)0.40